11 news items
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
JAZZ
20 Jun 24
) released topline results from the Phase 2b trial evaluating the efficacy and safety of suvecaltamide (JZP385), an investigational, highly
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
JAZZ
20 Jun 24
clinical trial (NCT05122650) evaluating the efficacy and safety of suvecaltamide (JZP385), an investigational, highly selective and state-dependent modulator
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
favorable safety profile, significantly reducing the risks of sepsis and mucositis compared to traditional care, further advocating its role as a safer
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
The primary objectives of the THIO-101 trial are to assess the safety and tolerability of THIO and its efficacy in terms of ORR. To date, THIO, combined
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
JAZZ
1 Jun 24
with zanidatamab. The safety profile in all enrolled patients remained manageable with favorable tolerability compared with the initial analysis. Two (2.3
4611y9zl0bb16n4w7 n0irdeucu28isoc0yl3ipff8ykfamvj
JAZZ
30 May 24
of Xywav efficacy and safety data in patients with narcolepsy with or without a medical history of psychiatric and/or neurologic comorbidities
aad2isbet6m4fk 7uqux60guh0a
JAZZ
29 May 24
the efficacy and safety of zanidatamab in combination with standard-of-care therapy against
ygjzdh5vvqk51lprub0w2dterulw9v4m28jz9hko35c4z66m2f 09xg4srmy
ABBV
AMGN
CURLF
18 May 24
by licensed pharmacists, aiming to ensure patient safety and product consistency.
To learn more about all of this and how to invest
stcibjeyev64458mz
AMGN
CASI
JAZZ
7 May 24
12 weeks of treatment and affirmed VK2809's potent effect on liver fat, along with its favorable tolerability and safety profile. Viking plans
d1s58kjrsvr mfdq0q5pp5xcx4ndxav9cbv3bv3z
JAZZ
24 Apr 24
safety
xvl32kz0jge96nggno2v74ce5iy20cncwpzlti7w82wm7w
JAZZ
10 Apr 24
, with an acceptable safety profile.Two posters assessing the impact
- Prev
- 1
- Next